Maswali yanayounganishwa na mwongozo · Kati Kiwango

AI katika Maswali ya Majaribio ya Kliniki

Kagua jinsi AI inavyoauni ulinganifu wa mgonjwa, muundo wa majaribio, tafiti zinazobadilika, ufuatiliaji wa usalama, na uthibitishaji wa udhibiti katika utafiti wa kimatibabu.

Njia za mwongozo zinazohusianaAI Katika Majaribio ya Kliniki
Swali 1 ya 8

Ni tatizo gani la muda mrefu katika majaribio ya kliniki ambalo AI inalenga moja kwa moja?

Hakiki kila swali8 maswali

Majibu na maelezo huonekana unapojibu maswali.

  1. Ni tatizo gani la muda mrefu katika majaribio ya kliniki ambalo AI inalenga moja kwa moja?
    • Kuajiri wagonjwa polepole na ngumu
    • Rangi ya ufungaji wa dawa
    • Menyu ya mkahawa wa hospitali
    • Upatikanaji wa maegesho katika tovuti za majaribio
  2. How can natural-language processing help screen patients for clinical trials?
    • Kwa kuruka ukaguzi wa usalama
    • Extract clinical information from electronic health records and compare it with trial eligibility criteria
    • Kwa kulipa wagonjwa zaidi ya washindani
    • Kwa kufupisha kesi hadi siku moja
  3. What is an external control arm in a clinical trial?
    • Kiungo bandia cha roboti
    • Molekuli ya dawa inayozalishwa na kompyuta
    • A comparison group drawn from data outside the trial, such as historical or concurrent external data
    • Seva ya data ya chelezo
  4. What can propensity-score matching do when constructing an external-control comparison?
    • Upangaji wa alfabeti
    • Uzalishaji wa nambari bila mpangilio pekee
    • Ukaguzi wa tahajia
    • Balance measured baseline covariates related to treatment assignment
  5. Kwa nini mifano ya utabiri ya kuacha shule na utendakazi wa tovuti ni muhimu kwa wafadhili wa majaribio?
    • Wanaruhusu wafadhili kuingilia kati kabla ya kukwama kwa majaribio
    • Wanatengeneza usanifu wa jengo
    • Wanaandika kauli mbiu za uuzaji
    • Wanachagua sare za wafanyakazi
  6. What does FDA’s January 2025 draft AI guidance address for drugs and biologics?
    • Ili kupunguza kasi ya utafiti wote kabisa
    • AI used to generate information supporting regulatory decisions about safety, effectiveness, or quality
    • Kwa sababu AI ni haramu katika dawa
    • Ili kupunguza idadi ya madaktari
  7. What can a Bayesian adaptive clinical-trial design change as evidence accumulates?
    • The original trial question after results are known
    • The identity of past participants
    • Trial elements such as dosing or allocation to study arms under prespecified rules
    • The inclusion criteria without documentation
  8. Which pharmacovigilance tasks does FDA identify as possible uses for emerging AI?
    • Only advertising click-through rates
    • Satellite images of clinical sites
    • Unrelated social-media sentiment about packaging
    • Adverse-event intake, data entry, processing, and safety-signal detection or evaluation